Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for thyroid
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on thyroid or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on thyroid and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
Afirma thyroid FNA analysis (Veracyte) Afirma thyroid FNA analysis (Veracyte) Afirma thyroid FNA analysis (Veracyte) HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc. Afirma thyroid FNA analysis (Veracyte) Lansdale: HAYES, Inc. Genetic Testing Publication. 2017 Authors' conclusions In recent years, significant advances in understanding (...) the genetic mechanisms of thyroid cancer have changed the way thyroid nodules are treated clinically. Several molecular targets have been associated with malignancy, including microRNA (miRNA), a noncoding endogenous form of RNA that helps regulate gene expression. Previous investigations have detected the dysregulation of miRNAs in malignant thyroid nodules, identifying the potential role of miRNAs in differentiating benign thyroid nodules from malignant ones. The Afirma Thyroid FNA Analysis
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer Purpose To investigate the risk and outcomes of second hematologic malignancies (SHMs) in a population-based cohort of patients with well-differentiated thyroid cancer (WDTC) treated or not with radioactive iodine (RAI). Methods Patients with WDTC were identified from SEER registries. Competing risk regression analysis was performed to calculate the risks of SHMs that occurred after WDTC treatment
Thyroid Cancer: Screening Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation Adults The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. D View the Clinical Summary in Population Asymptomatic adults Recommendation Do not screen for thyroid cancer. Grade: D Risk Assessment Factors that substantially increase the risk for thyroid cancer include a history of radiation exposure to the head (...) and neck as a child, exposure to radioactive fallout, family history of thyroid cancer in a first-degree relative, and certain genetic conditions, such as familial medullary thyroid cancer or multiple endocrine neoplasia syndrome (type 2A or 2B). Screening Tests Evidence is inadequate to estimate the accuracy of neck palpation or ultrasound of the thyroid as screening tests for thyroid cancer in asymptomatic persons. Treatment Surgery (ie, total or partial thyroidectomy, with or without lymphadenectomy
Activated charcoal for preoperative localization of thyroid cancer recurrence Activated charcoal for preoperative localization of thyroid cancer recurrence Activated charcoal for preoperative localization of thyroid cancer recurrence Klappenbach R, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A, López A, Rey-Ares L Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation Klappenbach R, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A, López A, Rey-Ares L. Activated charcoal for preoperative localization of thyroid cancer recurrence. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rapida No. 501. 2016 Authors' conclusions Very low-quality evidence does not allow drawing conclusions on activated charcoal for preoperative localization
Association between screening and the thyroid cancer "epidemic" in South Korea: evidence from a nationwide study. To investigate whether screening for thyroid cancer led to the current "epidemic" in South Korea. Review of the medical records of nationally representative samples of patients with a diagnosis of thyroid cancer in 1999, 2005, and 2008. Sample cases were randomly selected from South Korea's nationwide cancer registry, using a systematic sampling method after stratification (...) by region. 5796 patients with thyroid cancer were included (891 in 1999, 2355 in 2005, and 2550 in 2008). The primary outcome was age standardised incidence of thyroid cancer and the changes in incidence between 1999 and 2008 according to the methods used to detect tumours (screen detection versus clinical detection versus unspecified). Between 1999 and 2008, the incidence of thyroid cancer increased 6.4-fold (95% confidence interval 4.9-fold to 8.4-fold), from 6.4 (95% confidence interval 6.2 to 6.6
Minimally invasive and remoteâ€access thyroid surgery in the era of the 2015 American Thyroid Association guidelines Thyroid surgery has evolved throughout the years from being one of the most dangerous surgeries to becoming one of the safest surgical procedures performed today. Recent technologic innovations have allowed surgeons to remove the thyroid gland from a remote site while avoiding visible neck scars. There are many endoscopic approaches for thyroidectomy. The most common cervical (...) the surgeons in accomplishing remote-access thyroid surgery under the scope of the 2015 American Thyroid Association Guidelines.
Newborn Screening for Thyroid-stimulating Hormone as an Indicator for Assessment of Iodine Status in the Republic of Macedonia Iodine deficiency is associated with goiter and impaired brain function leading to cretinism. An increased frequency of thyroid-stimulating hormone (TSH) measurements above 5 mlU/L on newborn screening points toward an impaired iodine status of the population.A 13-year retrospective analysis was performed in 228,266 newborns participating in the national thyroid newborn
Thyroid Stimulating Hormone (TSH) in the Evaluation of Subclinical Hypothyroidism 27755618 2016 11 07 2018 11 13 1538-3598 316 15 2016 Oct 18 JAMA JAMA Thyroid-Stimulating Hormone in the Evaluation of Subclinical Hypothyroidism. 1592-1593 10.1001/jama.2016.9534 Papaleontiou Maria M Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor. Cappola Anne R AR Division of Endocrinology, Diabetes, and Metabolism, Perelman School of Medicine at the University
Lacrimal gland enlargement as an early clinical or radiological sign in thyroid orbitopathy Characteristic ophthalmic signs of Thyroid Orbitopathy (TO) include exophthalmos, eyelid retraction, eyelid edema, restrictive extraocular myopathy, and optic neuropathy. In addition lacrimal gland (LG) enlargement can be observed in these patients. However TO has not usually been considered in the differential diagnosis of cases of isolated LG enlargement.A female patient at our institution (Texas Tech (...) to better understand the timing of LG involvement. In patients presenting with lacrimal gland enlargement, thyroid orbitopathy should be strongly considered in the differential diagnosis together with other causes of dacryoadenitis and LG tumors. This may save unnecessary and extensive diagnostic testing or even LG biopsies.
Lenvima for Differentiated Thyroid Cancer – Details Lenvima for Differentiated Thyroid Cancer – Details | CADTH.ca Find the information you need Lenvima for Differentiated Thyroid Cancer – Details Lenvima for Differentiated Thyroid Cancer – Details Project Number pCODR 10080 Brand Name Lenvima Generic Name Lenvatinib Strength 4mg and 10mg Capsules Tumour Type Endocrine Indication Differentiated Thyroid Cancer Funding Request For the treatment of patients with locally recurrent or metastatic
Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. 27532827 2016 08 23 2016 08 18 1533-4406 375 7 2016 Aug 18 The New England journal of medicine N. Engl. J. Med. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. 614-7 10.1056/NEJMp1604412 Vaccarella Salvatore S From the International Agency for Research on Cancer, Lyon, France (S.V., S.F., F.B., C.P.W., M.P.); and the Cancer Epidemiology Unit, CRO (Centro di Riferimento Oncologico) Aviano (...) Male Medical Overuse trends Middle Aged Thyroid Neoplasms diagnosis epidemiology Young Adult 2016 8 18 6 0 2016 8 18 6 0 2016 8 24 6 0 ppublish 27532827 10.1056/NEJMp1604412
Thyroid Ophthalmopathy, Dermopathy, and Acropachy. 27468062 2016 08 09 2016 07 29 1533-4406 375 3 2016 Jul 21 The New England journal of medicine N. Engl. J. Med. IMAGES IN CLINICAL MEDICINE. Thyroid Ophthalmopathy, Dermopathy, and Acropachy. 261 10.1056/NEJMicm1506674 Guerrero Carlo C Maricopa Medical Center, Phoenix, AZ firstname.lastname@example.org. Pittelkow Mark R MR Mayo Clinic, Scottsdale, AZ. eng Case Reports Journal Article United States N Engl J Med 0255562 0028-4793 AIM IM Fingers
Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence. To determine whether the use of imaging tests after primary treatment of differentiated thyroid cancer is associated with more treatment for recurrence and fewer deaths from the disease. Population based retrospective cohort study. Surveillance Epidemiology and End Results-Medicare database in the United States. 28 220 patients (...) diagnosed with differentiated thyroid cancer between 1998 and 2011. The study cohort was followed up to 2013, with a median follow-up of 69 months. Treatment for recurrence of differentiated thyroid cancer (additional neck surgery, additional radioactive iodine treatment, or radiotherapy), and deaths due to differentiated thyroid cancer. We conducted propensity score analyses to assess the relation between imaging (neck ultrasound, radioiodine scanning, or positron emission tomography (PET) scanning